Data from large clinical trials were used to determine the frequency of adverse reactions. The following convention has been used for the classification of frequency: Very common (≥1/10); common (≥1/100 and <1/10); uncommon (≥1/1,000 and <1/100); rare (≥1/10,000 and <1/1,000); very rare (<1/10,000).
Clinical Trial Data: (see Table 2).
Click on icon to see table/diagram/image
Children: (see Table 3).
Click on icon to see table/diagram/image
Post-Marketing Data: (see Table 4).
Click on icon to see table/diagram/image